Clinical Trial Update: VA Aripiprazole vs Esketamine for Treatment Resistant Depression [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing aripiprazole vs esketamine for treatment-resistant depression was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• ARIPIPRAZOLE (Aripiprazole)
• Esketamine (esketamine)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Depressive Disorder, Major | Phase 4 | Status: WITHDRAWN